Masayuki Saijo

InstitutionNational Institute of Infectious Diseases
AddressTokyo
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 4 Covid-19 publications, with a maximum of 1 publications in November 2020 and January 2021 and February 2021 and March 2021
    All Publications
    Bar chart showing 301 publications over 27 distinct years, with a maximum of 33 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ohashi H, Watashi K, Saso W, Shionoya K, Iwanami S, Hirokawa T, Shirai T, Kanaya S, Ito Y, Kim KS, Nomura T, Suzuki T, Nishioka K, Ando S, Ejima K, Koizumi Y, Tanaka T, Aoki S, Kuramochi K, Suzuki T, Hashiguchi T, Maenaka K, Matano T, Muramatsu M, Saijo M, Aihara K, Iwami S, Takeda M, McKeating JA, Wakita T. Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment. iScience. 2021 Apr 23; 24(4):102367. PMID: 33817567.
      Citations: 19     
    2. Yamada S, Fukushi S, Kinoshita H, Ohnishi M, Suzuki T, Fujimoto T, Saijo M, Maeda K. Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells. BMJ Open Respir Res. 2021 02; 8(1). PMID: 33627333.
      Citations: 3     Translation:HumansAnimalsCells
    3. Tani H, Kimura M, Tan L, Yoshida Y, Ozawa T, Kishi H, Fukushi S, Saijo M, Sano K, Suzuki T, Kawasuji H, Ueno A, Miyajima Y, Fukui Y, Sakamaki I, Yamamoto Y, Morinaga Y. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein. Virol J. 2021 01 12; 18(1):16. PMID: 33435994.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    4. Doi Y, Hibino M, Hase R, Yamamoto M, Kasamatsu Y, Hirose M, Mutoh Y, Homma Y, Terada M, Ogawa T, Kashizaki F, Yokoyama T, Koba H, Kasahara H, Yokota K, Kato H, Yoshida J, Kita T, Kato Y, Kamio T, Kodama N, Uchida Y, Ikeda N, Shinoda M, Nakagawa A, Nakatsumi H, Horiguchi T, Iwata M, Matsuyama A, Banno S, Koseki T, Teramachi M, Miyata M, Tajima S, Maeki T, Nakayama E, Taniguchi S, Lim CK, Saijo M, Imai T, Yoshida H, Kabata D, Shintani A, Yuzawa Y, Kondo M. A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19. Antimicrob Agents Chemother. 2020 11 17; 64(12). PMID: 32958718.
      Citations: 41     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    5. Kato H, Takayama-Ito M, Iizuka-Shiota I, Fukushi S, Posadas-Herrera G, Horiya M, Satoh M, Yoshikawa T, Yamada S, Harada S, Fujii H, Shibamura M, Inagaki T, Morimoto K, Saijo M, Lim CK. Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice. PLoS One. 2019; 14(10):e0223684. PMID: 31589656.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    6. Fukushi S, Fukuma A, Kurosu T, Watanabe S, Shimojima M, Shirato K, Iwata-Yoshikawa N, Nagata N, Ohnishi K, Ato M, Melaku SK, Sentsui H, Saijo M. Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA. J Virol Methods. 2018 01; 251:22-29. PMID: 28993122.
      Citations: 16     Fields:    Translation:AnimalsCells
    7. Fukuma A, Tani H, Taniguchi S, Shimojima M, Saijo M, Fukushi S. Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein. Arch Virol. 2015 Sep; 160(9):2293-300. PMID: 26138557.
      Citations: 11     Fields:    Translation:AnimalsCells
    8. Shirato K, Maeda K, Tsuda S, Suzuki K, Watanabe S, Shimoda H, Ueda N, Iha K, Taniguchi S, Kyuwa S, Endoh D, Matsuyama S, Kurane I, Saijo M, Morikawa S, Yoshikawa Y, Akashi H, Mizutani T. Detection of bat coronaviruses from Miniopterus fuliginosus in Japan. Virus Genes. 2012 Feb; 44(1):40-4. PMID: 21877208.
      Citations: 10     Fields:    Translation:AnimalsCells
    9. Nagata N, Iwata N, Hasegawa H, Fukushi S, Harashima A, Sato Y, Saijo M, Taguchi F, Morikawa S, Sata T. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Am J Pathol. 2008 Jun; 172(6):1625-37. PMID: 18467696.
      Citations: 52     Fields:    Translation:HumansAnimalsCells
    10. Ami Y, Nagata N, Shirato K, Watanabe R, Iwata N, Nakagaki K, Fukushi S, Saijo M, Morikawa S, Taguchi F. Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice. Microbiol Immunol. 2008 Feb; 52(2):118-27. PMID: 18380809.
      Citations: 10     Fields:    Translation:AnimalsCells
    11. Nagata N, Iwata N, Hasegawa H, Sato Y, Morikawa S, Saijo M, Itamura S, Saito T, Ami Y, Odagiri T, Tashiro M, Sata T. Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes. Int J Exp Pathol. 2007 Dec; 88(6):403-14. PMID: 18039277.
      Citations: 6     Fields:    Translation:AnimalsCells
    12. Fukushi S, Mizutani T, Sakai K, Saijo M, Taguchi F, Yokoyama M, Kurane I, Morikawa S. Amino acid substitutions in the s2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells. J Virol. 2007 Oct; 81(19):10831-4. PMID: 17652383.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    13. Ikejiri M, Saijo M, Morikawa S, Fukushi S, Mizutani T, Kurane I, Maruyama T. Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents. Bioorg Med Chem Lett. 2007 May 01; 17(9):2470-3. PMID: 17336519.
      Citations: 11     Fields:    Translation:AnimalsCells
    14. Mizutani T, Fukushi S, Kenri T, Sasaki Y, Ishii K, Endoh D, Zamoto A, Saijo M, Kurane I, Morikawa S. Enhancement of cytotoxicity against Vero E6 cells persistently infected with SARS-CoV by Mycoplasma fermentans. Arch Virol. 2007; 152(5):1019-25. PMID: 17277901.
      Citations: 1     Fields:    Translation:AnimalsCells
    15. Nagata N, Iwata N, Hasegawa H, Fukushi S, Yokoyama M, Harashima A, Sato Y, Saijo M, Morikawa S, Sata T. Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol. 2007 Feb; 81(4):1848-57. PMID: 17151094.
      Citations: 30     Fields:    Translation:AnimalsCells
    16. Fukushi S, Mizutani T, Saijo M, Kurane I, Taguchi F, Tashiro M, Morikawa S. Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV. J Med Virol. 2006 Dec; 78(12):1509-12. PMID: 17063504.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    17. Mizutani T, Fukushi S, Ishii K, Sasaki Y, Kenri T, Saijo M, Kanaji Y, Shirota K, Kurane I, Morikawa S. Mechanisms of establishment of persistent SARS-CoV-infected cells. Biochem Biophys Res Commun. 2006 Aug 18; 347(1):261-5. PMID: 16808902.
      Citations: 16     Fields:    Translation:AnimalsCells
    18. Mizutani T, Fukushi S, Iizuka D, Inanami O, Kuwabara M, Takashima H, Yanagawa H, Saijo M, Kurane I, Morikawa S. Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cells. FEMS Immunol Med Microbiol. 2006 Mar; 46(2):236-43. PMID: 16487305.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    19. Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells. FEBS Lett. 2006 Feb 20; 580(5):1417-24. PMID: 16458888.
      Citations: 7     Fields:    Translation:AnimalsCells
    20. Mizutani T, Fukushi S, Saijo M, Kurane I. Characterization of persistent SARS-CoV infection in Vero E6 cells. Adv Exp Med Biol. 2006; 581:323-6. PMID: 17037553.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    21. Nagata N, Iwata N, Hasegawa H, Asahi-Ozaki Y, Sato Y, Harashima A, Morikawa S, Saijo M, Itamura S, Saito T, Odagiri T, Tashiro M, Ami Y, Sata T. Pathological and virological analyses of severe acute respiratory syndrome-associated coronavirus infections in experimental animals. Adv Exp Med Biol. 2006; 581:515-8. PMID: 17037588.
      Citations:    Fields:    Translation:AnimalsCells
    22. Fukushi S, Mizutani T, Saijo M, Matsuyama S, Taguchi F, Kurane I, Morikawa S. Pseudotyped vesicular stomatitis virus for functional analysis of SARS coronavirus spike protein. Adv Exp Med Biol. 2006; 581:293-6. PMID: 17037546.
      Citations: 2     Fields:    Translation:HumansCells
    23. Ikejiri M, Saijo M, Morikawa S, Fukushi S, Mizutani T, Kurane I, Maruyama T. Anti-SARS-CoV activity of nucleoside analogs having 6-chloropurine as a nucleobase. Nucleic Acids Symp Ser (Oxf). 2006; (50):113-4. PMID: 17150843.
      Citations: 1     Fields:    Translation:Cells
    24. Fukushi S, Mizutani T, Saijo M, Matsuyama S, Miyajima N, Taguchi F, Itamura S, Kurane I, Morikawa S. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol. 2005 Aug; 86(Pt 8):2269-2274. PMID: 16033974.
      Citations: 72     Fields:    Translation:HumansAnimalsCells
    25. Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. JNK and PI3k/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells. Biochim Biophys Acta. 2005 Jun 30; 1741(1-2):4-10. PMID: 15916886.
      Citations: 37     Fields:    Translation:AnimalsCells
    26. Saijo M, Ogino T, Taguchi F, Fukushi S, Mizutani T, Notomi T, Kanda H, Minekawa H, Matsuyama S, Long HT, Hanh NT, Kurane I, Tashiro M, Morikawa S. Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS. J Virol Methods. 2005 May; 125(2):181-6. PMID: 15794988.
      Citations: 8     Fields:    Translation:AnimalsCells
    27. Saijo M, Morikawa S, Fukushi S, Mizutani T, Hasegawa H, Nagata N, Iwata N, Kurane I. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus. Antiviral Res. 2005 Jun; 66(2-3):159-63. PMID: 15911031.
      Citations: 34     Fields:    Translation:AnimalsCells
    28. Mizutani T, Fukushi S, Murakami M, Hirano T, Saijo M, Kurane I, Morikawa S. Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells. FEBS Lett. 2004 Nov 05; 577(1-2):187-92. PMID: 15527783.
      Citations: 31     Fields:    Translation:AnimalsCells
    29. Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells. Virology. 2004 Oct 01; 327(2):169-74. PMID: 15351204.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    30. Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells. Biochem Biophys Res Commun. 2004 Jul 09; 319(4):1228-34. PMID: 15194498.
      Citations: 59     Fields:    Translation:AnimalsCells